The myeloproliferative blood cancers—essential thrombocytosis (ET

Blood and Hematology - Essential Thrombocythemia Thrombocytosis (platelet count ≥450,000 per cubic millimeter) is frequently encountered in clinical practice, with a reported prevalence of 1.9% in a large study involving ambulatory patients

PDF) Myeloproliferative blood cancers as a human neuroinflammation

Christina ELLERVIK, MD, PhD

Essential thrombocythemia (ET) – MPN Research Foundation

What Causes Essential Thrombocythemia?

Primary thrombocytosis in children

Troels WIENECKE Chief Physician, clinical associate professor

Pathophysiology of thrombosis in myeloproliferative neoplasms

Frontiers Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study

Diet and Nutrition Tips for People Living With MPNs

Blast phase myeloproliferative neoplasm: contemporary review and 2024 treatment algorithm